Effects of bezafibrate treatment in a patient and a carrier with mutations in the PNPLA2 gene, causing neutral lipid storage disease with myopathy.
van de Weijer T, Havekes B, Bilet L, Hoeks J, Sparks L, Bosma M, Paglialunga S, Jorgensen J, Janssen MC, Schaart G, Sauerwein H, Smeets JL, Wildberger J, Zechner R, Schrauwen-Hinderling VB, Hesselink MK, Schrauwen P.
van de Weijer T, et al.
Circ Res. 2013 Mar 1;112(5):e51-4. doi: 10.1161/CIRCRESAHA.113.300944.
Circ Res. 2013.
PMID: 23449549
No abstract available.